Navigation Links
Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
Date:12/11/2007

evelops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life- threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. Visit Gilead on the World Wide Web at http://www.gilead.com.

Forward-Looking Statements

Bristol-Myers Squibb Forward-Looking Statement

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding product development. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks, there can be no guarantee that ATRIPLA will receive regulatory approval in the European Union or other geographies. Forward-looking statements in this press release should be evaluated together with the many risks and uncertainties that affect Bristol-Myers Squibb's business, including those identified in Bristol-Myers Squibb's Annual Report on Form 10-K for the year ended December 31, 2006 and in our Quarterly Reports on Form 10-Q, particularly under "Item 1A. Risk Factors". Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Gilead Sciences Forward-Looking Statement

This press release includes forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that are subject to risks, uncertainties and other factors, including the risk that the European Commission will not formally approve ATRIPLA for marketing in
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
2. Merck/Gilead Once-A-Day AIDS Pill Not Available in Most Places - AHF Urges Speed-Up of Registrations
3. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
4. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
7. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
8. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
9. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
10. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
11. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015 On August 31, 2015, ... , issued a 123-page order in the first of ... Conserve metal-on-metal hip replacement devices are defective.[1]  ... as to Plaintiff Robyn Christiansen,s claims for defective design, ... flatly rejected Wright Medical,s claim that the Medical Device ...
(Date:9/1/2015)... , Sept. 1, 2015  AccuTec Blades, Inc. ... (EPC) Industrial Blades division.  EPC announced in May 2015 ... Verona, Virginia and ... of the sale process. Rick ... of AccuTec Blades said, "Our new name, AccuTec Blades, ...
(Date:9/1/2015)... , Sept. 1, 2015 Ardelyx, ... company focused on gastrointestinal and cardio-renal diseases, today ... of the option and license agreement for Ardelyx,s ... There was no payment associated with termination and ... 2014, Ardelyx and Sanofi entered into an option ...
Breaking Medicine Technology:Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 2Pope McGlamry: Omnibus order in Conserve Hips MDL-2329 sets stage for bellwether trial 3AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3
(Date:9/2/2015)... ... September 02, 2015 , ... ... content, records and case management solutions and services to both government and commercial ... Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC ...
(Date:9/2/2015)... ... September 02, 2015 , ... Available ... marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich Cream , an evolution ... biotechnological anti-aging power with a lipid-replenishing marine oil for intense nourishing and moisturizing. ...
(Date:9/2/2015)... ... September 02, 2015 , ... Dr. Robert G. Schwartz , ... now certified in “Systema”: a Russian martial art system that is also a philosophy ... Systema , which dates back to the 10th century, is a Russian Martial ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... plastic surgeries conducted each year on teenagers, quoting a New York City-area plastic ... Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to patients ...
(Date:9/1/2015)... ... September 02, 2015 , ... The Journal of Pain Research ... in the USA ”. , As corresponding author Mr Christopher Malone says “Migraine headache ... our study, we endeavoured to better understand how migraine headaches impact the lives of ...
Breaking Medicine News(10 mins):Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 2Health News:Dr. Robert G. Schwartz Achieves Certification in Russian Martial Art “Systema” and Focuses on Integrating Techniques & Principles into Health Care Delivery 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2
... France June 04, 2009 The cause of ... after Alzheimer,s disease, is unknown, but in most cases ... risk factors and genetic susceptibility. Laboratory studies in rats ... an animal model of PD and several epidemiological studies ...
... BioTrends Research Group, Inc. announces the release of the baseline ... The survey was completed by U.S. Rheumatologists in May 2009, ... , Once monthly dosing seems to be playing well, according ... of SIMPONI. 84% of the Rheumatologists surveyed report that they ...
... Pa., June 4 Herley Industries, Inc. (Nasdaq: ... Israel, has recently received contracts valued at approximately $4 million ... customer. These are follow-on awards for an existing customer ... to a U.S. aircraft. , , Herley Industries, Inc. ...
... The Cardiovascular Nurse and Technologist Symposium at TCT 2009 ... clinical/administrative strategies for the management of the cardiovascular patient: ... receiving PCI, Revascularization decisions, Management decisions regarding patients with ... charge of your own health WHEN: ...
... uninterrupted supply for customers , , LAKE ZURICH, Ill., ... improving blood collection, safety and availability for patient care, said ... a patent lawsuit brought by Haemonetics Corporation in 2005. ... , , In conjunction with this litigation, ...
... , For Father,s Day, Forget The Usual With A Gift ... Physician Formulated Anti-Wrinkle Moisturizer , , PACIFIC PALISADES, Calif., ... This year, give Dad something he secretly desires but may ... the best for the family hero. Dermagenics Physician-Formulated ...
Cached Medicine News:Health News:Association found between Parkinson's disease and pesticide exposure in French farm workers 2Health News:Once Monthly Dosing: How Much of a Competitive Advantage is it? Rheumatologists Provide Insight in the Baseline Report of LaunchTrends(TM): SIMPONI(TM) 2Health News:Herley's Israeli Subsidiary, GMI Eyal, is Selected to Provide Complex Microwave Switch Assemblies for a U.S. Customer 2Health News:Nurses: Providing angioplasty patient care in and out of the cath lab 2Health News:Fenwal Statement Regarding Patent Litigation 2Health News:SHOW DAD YOU LOVE HIS FACE 2
... The VersaPulse PowerSuite holmium laser ... properties for precise, virtually bloodless procedures. ... fragmenting urinary and gall bladder stones ... ideal multipurpose surgical tool. Because its ...
... Nd:YAG technology has allowed for perfecting mini-invasive ... of various pathologies with a considerable social ... for reducing the post-operatory times and represents ... costs in all hospital structures.,DEKAs family of ...
... have to choose. The Apogee Elite ... 755nm Alexandrite laser and a high ... in one convenient unit. The ... for hair removal, pigmented lesions, facial ...
Single use trocar with non-conductive sleeves for gaining and maintaining thoracic access., ,THORACOPORT™ devices are trocars used to gain access to the thoracic cavity for use in video assis...
Medicine Products: